Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers
Completed · Phase 1 · Has a placebo group
Conditions studied: Flu
In brief
The purpose is of this study is to assess the safety and tolerability of three dose levels of H3N2 M2SR influenza vaccine versus placebo delivered intranasally to healthy adult subjects.
Key facts
- Study ID
- NCT02822105
- Run by
- FluGen Inc
- People needed
- 96
- Starts
- 2016-06-01
- Expected to finish
- 2017-11-01
- Last updated by the study team
- 2020-08-10
Who can join
Age: 18 and older, up to 49. Sex: any. Healthy volunteers: accepted.
Where it is running
- JCCT — Lenexa, Kansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.